Furthermore, testing 54 CRC patients with positive expression of DOCK2 and 54 control patients revealed that DOCK2 expression levels were positively correlated with CD8+ T cell counts and T cells expressing both DOCK2 and CD8 showed the best prognosis in CRC patients. Here, CD8A is linked to colorectal carcinoma.